Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
International Journal of Cancer
|
July 13, 2017
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia
Fangyi Gu, Han Zhang, Paula L Hyland, et al.
British Journal of Cancer
|
March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
International Journal of Epidemiology
|
December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies
Lauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology
|
April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Weiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute
|
February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium
Britton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
British Journal of Cancer
|
August 18, 2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report
Albina N Minlikeeva, Jo L Freudenheim, Rikki A Cannioto, et al.
Human Molecular Genetics
|
March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
Celeste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
American Journal of Epidemiology
|
October 5, 2016
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci
Merlise A Clyde, Rachel Palmieri Weber, Edwin S Iversen, et al.
Journal of the National Cancer Institute
|
August 9, 2020
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies
Alice W Lee, Stacey Rosenzweig, Ashley Wiensch, et al.
The Lancet. Oncology
|
February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
International Journal of Cancer
|
July 13, 2017
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia
Fangyi Gu, Han Zhang, Paula L Hyland, et al.
British Journal of Cancer
|
March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
International Journal of Epidemiology
|
December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies
Lauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology
|
April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Weiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute
|
February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium
Britton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
British Journal of Cancer
|
August 18, 2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report
Albina N Minlikeeva, Jo L Freudenheim, Rikki A Cannioto, et al.
Human Molecular Genetics
|
March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
Celeste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
American Journal of Epidemiology
|
October 5, 2016
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci
Merlise A Clyde, Rachel Palmieri Weber, Edwin S Iversen, et al.
Journal of the National Cancer Institute
|
August 9, 2020
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies
Alice W Lee, Stacey Rosenzweig, Ashley Wiensch, et al.
The Lancet. Oncology
|
February 25, 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, et al.
Page
of 14